{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:19:31Z","timestamp":1790662771224,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.vaccine.2006.07.019","type":"journal-article","created":{"date-parts":[[2006,8,2]],"date-time":"2006-08-02T14:32:35Z","timestamp":1154529155000},"page":"64-71","source":"Crossref","is-referenced-by-count":25,"title":["Adjuvant effects of adenylate cyclase toxin of Bordetella pertussis after intranasal immunisation of mice"],"prefix":"10.1016","volume":"25","author":[{"given":"Barbara","family":"Orr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"Douce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Baillie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Parton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Coote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2006.07.019_bib1","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0031-3955(05)70209-1","article-title":"Acellular pertussis vaccines","volume":"47","author":"Decker","year":"2000","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.vaccine.2006.07.019_bib2","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1128\/JCM.13.2.286-292.1981","article-title":"Enzyme-linked immunosorbent assay for detection of pertussis immunoglobulin A in nasopharyngeal secretions as an indicator of recent infections","volume":"13","author":"Goodman","year":"1981","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2006.07.019_bib3","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1128\/IAI.61.2.399-410.1993","article-title":"Cell-mediated immunity to Bordetella pertussis: role of Th1 cells in bacterial clearance in a murine respiratory infection model","volume":"61","author":"Mills","year":"1993","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2006.07.019_bib4","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1128\/JCM.20.2.167-170.1984","article-title":"Characterisation of antibody inhibiting adherence of Bordetella pertussis to human respiratory epithelial cells","volume":"20","author":"Tuomanen","year":"1984","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2006.07.019_bib5","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1093\/infdis\/160.5.838","article-title":"Serum IgG, IgA and IgM responses to pertussis toxin, filamentous haemagglutinin and agglutinogens 2 and 3 after infection with Bordetella pertussis and immunization with whole-cell vaccine","volume":"160","author":"Thomas","year":"1989","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2006.07.019_bib6","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1128\/IAI.61.8.3190-3198.1993","article-title":"Effective immunization against Bordetella pertussis respiratory infection in mice is dependent on induction of cell-mediated immunity","volume":"61","author":"Redhead","year":"1993","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2006.07.019_bib7","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S1286-4579(01)01421-6","article-title":"Immunity to Bordetella pertussis","volume":"3","author":"Mills","year":"2001","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2006.07.019_bib8","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1128\/IAI.60.4.1482-1488.1992","article-title":"Mucosal immunization with filamentous haemagglutinin protects against Bordetella pertussis respiratory infection","volume":"60","author":"Shahin","year":"1992","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2006.07.019_bib9","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/0264-410X(93)90363-3","article-title":"Protection of mice against respiratory Bordetella pertussis infection by intranasal immunization with P.69 and FHA","volume":"11","author":"Roberts","year":"1993","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.07.019_bib10","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/0264-410X(95)00134-M","article-title":"Mucosal and systemic immunogenicity of a recombinant, non-ADP-ribosylating pertussis toxin: effects of formaldehyde treatment","volume":"13","author":"Cropley","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.07.019_bib11","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/0264-410X(94)00008-B","article-title":"Immune responses and protection against Bordetella pertussis after by intranasal immunization of mice with filamentous haemagglutinin in solution or incorporated in biodegradable microparticles","volume":"13","author":"Cahill","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.07.019_bib12","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0264-410X(02)00516-9","article-title":"Mucosal and systemic antibody responses against an acellular pertussis vaccine after intranasal co-administration with recombinant cholera toxin B subunit as an adjuvant","volume":"21","author":"Isaka","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.07.019_bib13","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1128\/IAI.63.6.2100-2108.1995","article-title":"A mutant pertussis toxin molecule that lacks ADP-ribosyltransferase activity, PT-9K\/129G, is an effective mucosal adjuvant for intranasally delivered proteins","volume":"63","author":"Roberts","year":"1995","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2006.07.019_bib14","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1016\/S0264-410X(00)00553-3","article-title":"Mucosal vaccines: non toxic forms of LT and CT as mucosal adjuvants","volume":"19","author":"Pizza","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.07.019_bib15","doi-asserted-by":"crossref","first-page":"6270","DOI":"10.1128\/IAI.67.12.6270-6280.1999","article-title":"Mutants of Escherichia coli heat-labile toxin act as effective mucosal adjuvants for nasal delivery of an acellular pertussis vaccine: differential effects of the nontoxic AB complex and enzyme activity on Th1 and Th2 cells","volume":"67","author":"Ryan","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2006.07.019_bib16","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1128\/IAI.58.10.3445-3447.1990","article-title":"Adenylate cyclase toxin is critical for lethal infection by Bordetella pertussis in infant mice","volume":"58","author":"Goodwin","year":"1990","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2006.07.019_bib17","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1084\/jem.193.9.1035","article-title":"The adenylate cyclase toxin of Bordetella pertussis binds to target cells via the alpha(M)beta(2) integrin (CD11b\/CD18)","volume":"193","author":"Guermonprez","year":"2001","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2006.07.019_bib18","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1128\/IAI.66.4.1718-1725.1998","article-title":"Role of adenylate cyclase-hemolysin in alveolar macrophage apoptosis during Bordetella pertussis infection in vivo","volume":"66","author":"Gueirard","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2006.07.019_bib19","doi-asserted-by":"crossref","first-page":"7152","DOI":"10.1128\/IAI.68.12.7152-7155.2000","article-title":"Neutralising antibodies to adenylate cyclase toxin promote phagocytosis of Bordetella pertussis by human neutrophils","volume":"68","author":"Weingart","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2006.07.019_bib20","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/infdis\/163.1.135","article-title":"Human serological responses to envelope associated proteins and adenylate cyclase toxin of Bordetella pertussis","volume":"163","author":"Arciniega","year":"1991","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2006.07.019_bib21","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1128\/IAI.61.9.3583-3589.1993","article-title":"CyaC mediated activation is important not only for toxic but also for protective activities of Bordetella pertussis adenylate cyclase-hemolysin","volume":"61","author":"Betsou","year":"1993","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2006.07.019_bib22","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1099\/00222615-32-3-173","article-title":"Antibodies to Bordetella pertussis adenylate cyclase are produced in man during pertussis infection and after vaccination","volume":"32","author":"Farfel","year":"1990","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.vaccine.2006.07.019_bib23","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1086\/381204","article-title":"Determination of serum antibody to Bordetella pertussis adenylate cyclase toxin in vaccinated and unvaccinated children and in children and adults with pertussis","volume":"38","author":"Cherry","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2006.07.019_bib24","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0882-4010(91)90038-C","article-title":"Protective activity of Bordetella adenylate cyclase-hemolysin against bacterial colonisation","volume":"11","author":"Guiso","year":"1991","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2006.07.019_bib25","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1574-695X.1999.tb01248.x","article-title":"Adjuvant and protective properties of native and recombinant Bordetella pertussis adenylate cyclase toxin preparations in mice","volume":"23","author":"Hormozi","year":"1999","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2006.07.019_bib26","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1128\/IAI.72.3.1568-1579.2004","article-title":"Adenylate cyclase toxin from Bordetella pertussis synergizes with lipopolysaccharide to promote innate interleukin-10 production and enhances the induction of Th2 and regulatory T cells","volume":"72","author":"Ross","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2006.07.019_bib27","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1016\/j.vaccine.2004.04.033","article-title":"Adjuvanticity of native and detoxified adenylate cyclase toxin of Bordetella pertussis towards co-administered antigens","volume":"22","author":"MacDonald-Fyall","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.07.019_bib28","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0378-1119(96)00412-X","article-title":"Bordetella pertussis adenylate cyclase toxin: proCyaA and CyaC proteins synthesised separately in Escherichia coli produce active toxin in vitro","volume":"180","author":"Westrop","year":"1996","journal-title":"Gene"},{"key":"10.1016\/j.vaccine.2006.07.019_bib29","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1128\/IAI.65.7.2821-2828.1997","article-title":"Intranasal immunogenicity and adjuvanticity of site-directed mutant derivatives of cholera toxin","volume":"65","author":"Douce","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2006.07.019_bib30","doi-asserted-by":"crossref","first-page":"888","DOI":"10.4049\/jimmunol.150.3.888","article-title":"Release of nitric oxide during the T-cell independent pathway of macrophage activation","volume":"150","author":"Beckerman","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2006.07.019_bib31","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1084\/jem.187.7.1123","article-title":"Mucosal adjuvanticity and immunogenicity of LTR72, a novel mutant of Escherichia coli heat-labile enterotoxin with partial knockout of ADP-ribosyltransferase activity","volume":"187","author":"Giuliani","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2006.07.019_bib32","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1046\/j.1462-5822.2003.00338.x","article-title":"From toxin to adjuvant: the rational design of a vaccine adjuvant vector, CTA1-DD\/ISCOM","volume":"6","author":"Lycke","year":"2004","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.vaccine.2006.07.019_bib33","doi-asserted-by":"crossref","first-page":"730","DOI":"10.4049\/jimmunol.175.2.730","article-title":"Bordetella pertussis adenylate cyclase toxin modulates innate and adaptive immune responses: distinct roles for acylation and enzymatic activity in immunomodulation and cell death","volume":"175","author":"Boyd","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2006.07.019_bib34","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/S0041-0101(02)00205-2","article-title":"The adenylate cyclase of Bordetella pertussis: a vector to target antigen presenting cells","volume":"40","author":"El Idrissi","year":"2002","journal-title":"Toxicon"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06008619?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06008619?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T11:14:26Z","timestamp":1683544466000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X06008619"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0264410X06008619"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2006.07.019","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}